Drug Profile
Research programme: drug discovery - BC Cancer Agency/Takeda
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator BC Cancer Agency; Takeda
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Metabolic disorders; Neurological disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Japan
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-disorders in Japan
- 16 Jul 2016 No recent reports of development identified for research development in Neurological-disorders in Japan